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Abstract
The pathogenesis of essential hypertension is not fully understood. Literature indicates the complexity of blood pres-
sure regulating mechanisms with a high impact of genetics and environmental factors. Previous experimental studies 
have shown the importance of salt intake in the development of hypertension. The aim of the study was to explore 
the influence of varying dietary sodium content on circadian blood pressure profile in patients with salt-sensitive 
hypertension. The study was carried out among 69 salt-sensitive hypertensive patients (19 females i 50 males) mean 
aged 36.1 ± 8.0 years. Study protocol provided low sodium diet firstly then high sodium diet containing 10–20 
mmol and 220–240 mmol of sodium per day respectively. On each of the diet ABPM was performed. Our results 
suggest that in salt-sensitive patients the reduction of salt intake may decrease blood pressure and restore its circadian 
profile and thus lead to the reduction in the rate of complications of hypertension.
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Introduction
The pathogenesis of essential hypertension is not 
fully understood. Literature indicates the complexity 
of blood pressure regulating mechanisms with a high 
impact of genetics and environmental factors. Previ-
ous experimental studies have shown the importance 
of salt intake in the development of hypertension. 
Since then blood pressure salt-sensivity is constantly 
studied. Depending on the blood pressure response 
to salt intake, patients are divided into salt-sensitive 
and salt-insensitive subjects. Salt-sensivity incidence 
among patients with hypertension is estimated at 
about 50% [1, 2] while in healthy subjects at ap-
proximately 20% [3, 4]. It is widely known that 
blood pressure salt-sensivity prevalence is more fre-
quent in black race and the elderly subjects than 
among caucasians and young people [5]. In addition, 
salt-sensitivity of blood pressure is common in obese 
patients with diabetes type 2 than those without the 
metabolic disorders [6, 7]. 
The mechanisms responsible for the blood pres-
sure response to high-sodium diet are complex and 
only partly clarified. The salt-sensivity phenomenon 
is probably based on the interaction between kidney 
and neuroendocrine factors such as atrial natriuretic 
peptide (ANP), kinins, prostaglandins, but the fur-
ther research are required for explanation. Salt-sen-
sitivity of blood pressure is connectedwith a higher 
mortality due to cardiovascular events such as myo-
cardial infarction and heart failure [8–12]. Large 
24-hour variability of blood pressure values and 
nocturnal decline absence are considered as a good 
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Table I. Clinical and biochemical characteristics of salt-sensitive 
hypertensive patients
Mean
n = 69
Age (years)  36.1	 ±	8.0
BMI [kg/m2]  23.5		±	0.9
SBP [mm Hg]  157.2		±	9.1
DBP [mm Hg]  101.4		±	3.1
MAP[mm Hg]  120.9		±	5.7
Serum sodium [mmol/l]  142.8		±	2.3
Serum potassium [mmol/l]  4.3		±	0.2
Uvol [ml/24h]  1210		±	201
UNa [ mmol/24h]  109.4		±	5.0
UK [mmol/24h]  49.9		±	4.7
Ccr [ml/min]  106.1		±	8.0
PRA [ng/AI/ml/h]  2.50		±	0.51
Aldosterone [pg/ml]  237.1		±	42.6
BMI — body mass index; SBP — systolic blood pressure; DBP — diastolic blood pressure; MAP — 
mean arterial pressure; Uvol — urine volume; UNa — sodium in 24h urine collection; UK — potassium 
in 24h urine collection; Ccr — creatinie clearance; PRA — plasma renin avtivity
indicators of cardiovascular complications in patients 
with arterial hypertension [13]. In clinical practice 
ABPM (Ambulatory Blood Pressure Monitoring) is 
the best way to evaluate blood pressure profile.
The aim of the study was to explore the infuence 
of varying dietary sodium content on cicardian blood 
pressure profile in patients with salt-sensitive hyper-
tension. 
Material and methods
The study was carried out among 69 salt-sensitive 
hypertensive patients (19 females i 50 males) mean 
aged 36.1 ± 8.0 years; with mean BMI 23.5 ± 0.9 
kg/m2. In refferance to current guidelines, hyper-
tension was diagnosed based on two different visits 
blood pressure measurments [16]. We excluded pa-
tients with prior diagnosis of secondary hyperten-
sion, heart failure, chronic kidney disease and those 
who were treated with hypertensive medications 
[17, 18]. Salt-sensivity hypertension was diagnosed 
in refferance to the Sullivan [4] and Bigazzi [19] 
criteria, according to which hypertension can be 
considered as salt-sensitive when the mean arteri-
al pressure (MAP) values rises above 10 mm Hg 
with a change in the sodium intake from 10–20 
mmol/24h (low sodium diet) to high: 220–240 
mmol/24h (high sodium diet). 
Study protocol provided low sodium diet firstly 
then high sodium diet containing 10–20 mmol and 
220–240 mmol of sodium per day respectively. The 
potassium content in all kinds of diet was constant at 
the level of 40–50 mmol/24h. Diet compliance was 
monitored by 24-h sodium excretion level in the 24-h 
urine collection. On each of the diet we performed 
24-hour blood pressure monitoring (ABPM) 
(Spacelabs Healthcare) and analyzed 24-hour, daytime 
and nocturnal systolic, diastolic, and mean values. 
Non-dipping blood pressure profile was defined as re-
duction of 0−10% in overnight blood pressure [20]. 
PRA (plasma renin activity with normal range: 
0.51–2.64 ng/ml/h), plasma aldosterone (normal 
range: 10–160 pg/ml), serum sodium and potassium 
level, creatine were measured using commercially 
available assays.
The statistical evaluation was performed by us-
ing Wilcoxon test and, for comparison of skewed-
ly distributed variables between the study groups, 
median values were calculated and Mann-Whitney 
U test was used. P values < 0.05 were considered 
significant. All analyses were carried out in Statistica 
(Statsoft, Inc. USA).
Results
Table I shows the clinical and biochemical charac-
teristics of patients with salt-sensitive hypertension.
Table II shows a comparison of mean (± SD) 
blood pressure, measured of ABPM method, in so-
dium sensitive hypertensive patients on low-sodium 
and high-sodium diet.
Patients with salt-sensivity blood pressure had 
significantly higher mean blood pressure values of 
all the analyzed ABPM parameters while receiving 
high-sodium diet. Moreover, the nocturnal pressure 
decline was significantly lower during high-sodium 
dieting compared to the low-sodium diet. 
Frequency of non-dippers and dippers in sodium 
sensitive hypertensive patients on low-and high-sodi-
um diet shown in Table III.
Along with increases in the salt intake frequencies 
of non-dippers profile was also increased, what was 
confirmed by c2 test (p < 0,001).
Table IV shows mean value (± SD) of creatinine 
clearance (Ccr), urinary sodium (UNa), potassium 
(UK), urinary volume (Uvol), concentrations of PRA 
and aldosterone in sodium sensitive hypertensive pa-
tients on low-and high-sodium diet. The 24-h sodi-
um excretion increased according to salt intake. No 
significant differences in potassium excretion, and 
urine volume has been observed.
In addition, along with increases in the salt intake 
PRA inhibition and aldosterone levels decrease was 
observed.
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Table II. The comparison of mean (± SD) blood pressure, estimated in ABPM method, in sodium sensitive hypertensive patients on low-
sodium and high-sodium diet
Low sodium diet High sodium diet p < 
24 SBP [mm Hg]  130.5  ± 5.8  145.8  ± 7.8 p < 0.001
24 DBP [mm Hg]  92.5  ± 7.9  102.3  ± 11.2 p < 0.001
24MAP [mm Hg]  109.4		±	5.5  125.3		±	4.5 p < 0.001
SBPd [mm Hg]  134.5  ± 10.2  152  ± 6.2 p < 0.001
DBPd [mm Hg ]  95.4  ± 6.3  106.2  ± 6.2 p < 0.001
MAPd [mm Hg]  115.4		±	5.0  130.2		±	4.3 p < 0.001 
SBPn [mm Hg]  110.1  ± 7.8  115.3  ± 8.9 p < 0.001
DBPn [mm Hg]  69.1  ± 5.4  75.1  ± 7.5 p < 0.001
MAPn [mm Hg]  101.8		±	5.9  119.3		±	5.9 p < 0.001
CV (%)  12.0		±	3.5  8.8		±	3.2 p < 0.001
24 SBP — 24-hour systolic blood pressure; 24 DBP — 24-hour diastolic blood pressure; 24 MAP — 24-hour mean arterial pressure; SBPd — daytime systolic blood pressure; DBPd — daytime diastolic blood pressure; 
MAPd — daytime mean arterial pressure; SBPn — nocturnal systolic blood pressure; DBPn — nocturnal diastolic blood pressure; MAPn — nocturnal mean arterial pressure; CV — coeff﻿icient of variation
Table III. The frequency of non-dippers and dippers in sodium 
sensitive hypertensive patients on low-and high-sodium diet
Non-dippers Dippers P value
Low-sodium diet 15
(21.7%)
54
(78.3%)
p < 0.001
c2 =16.73High-sodium diet 45
(65.0%)
24
(35.0%)
Table IV. The mean value (± SD) of creatinine clearance (Ccr), 
urinary sodium (UNa), potassium (UK), urinary volume (Uvol), 
concentrations of plasma renin activity (PRA) and aldosterone in 
sodium sensitive hypertensive patients on low-and high-sodium 
diet
Low sodium diet High sodium 
diet
P value
Ccr [ml/min] 103.5	±	7.3 116.8	±	12.6 p < 0.001
UNa 
[mmol/24h] 
21.8	±	6.3 241.5	±	6.4 p < 0.001
UK 
[mmol/24h] 
49.9	±	3.4 50.1	±	4.2 ns
Uvol 
[ml/24h] 
1183	±	137 1222	±	136 ns
PRA 
[ng/AI/ml/h] 
4.82	±	0.35 1.20	±	0.38 p < 0.05
Aldosterone 
[pg/ml] 
396.0	±	28.3 127.1	±	24.5 p < 0.001
Discussion
Basic advantages offered by 24h ABPM include 
the possibility to assess circadian blood pressure pro-
files, daytime and nocturnal blood pressure and its 
diurnal variations as well as the magnitude of noc-
turnal fall which allows to identify the dipper and 
non-dipper patterns [20, 24–27]. Moreover, it has 
been well documented that blood pressure values in 
ABPM better correlate with left ventricle mass, se-
verity of kidney damage, prevalence of cardiovascular 
events and changes in eye fundoscopy than blood 
pressure values measured by traditional methods 
[28–31]. It also has been suggested that ABPM has 
better sensitivity in the prediction of the rate of hy-
pertension complications and cardiovascular death, 
and overall prognosis [32, 33].
Our results suggest that diminished salt-induced 
nocturnal blood pressure fall could be a characteristic 
feature of salt-sensitive hypertension. Interestingly, 
many of dippers on a low sodium diet developed not 
desired non-dipping blood pressure pattern on a high 
sodium diet. This finding confirms a similar conclu-
sion reported in Japan population [21], although in 
humans the blood pressure performance in response 
to high salt load can be modulated by dietary potassi-
um intake [34]. The essential influence of dietary so-
dium on blood pressure profiles was demonstrated in 
experimental studies. In spontaneously hypertensive 
rats (SHR), a high sodium diet deteriorated normal 
circadian profile of blood pressure [35] suggesting the 
maintenance of stable dietary sodium as a crucial fac-
tor in assessments of variability and circadian rhythm 
of blood pressure; however, data regarding this issue 
are still scarce and hence, the mechanism of high 
blood pressure variability and diminished nocturnal 
fall in salt-sensitive patients receiving high sodium 
diet remains unclear [21, 34]. It should be noted that 
increasing evidence suggests that high sodium diet 
may alter several pathways regulating blood pressure, 
namely the sympathetic activity [2, 15], volemia [2], 
renin-angiotensin-aldosterone system activity [36], 
insulin release and insulin sensitivity [36, 37], intra-
cellular sodium and calcium concentration [36, 37], 
arterial hypertension 2016, vol. 20, no. 4
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kidney hemodynamics, and endogenous nitric oxide 
synthesis [38]. As all these pathways are greatly in-
volved in the modulation of circadian blood pressure 
profile and variation, it can be speculated that they 
may play a role in the diminution of nocturnal fall 
and increased variability of blood pressure observed 
in our study. Previous studies demonstrated that the 
activity of the autonomic nervous system, especial-
ly the sympathetic activity, influences the range of 
nocturnal fall [39, 40]. It has been suggested that in 
salt-sensitive subjects the retention of sodium and 
blood pressure increase are associated with increased 
sympathetic activity [41–44], resulting in a shift of 
the pressure-natriuresis mechanism [44] and increase 
of arterial reactivity to vasopressor compounds [42]. 
In healthy individuals, nocturnal fall is a result of 
dominating parasympathetic activity during sleep 
[45]. In this context, it can be assumed that in some 
hypertensive patients a shift from dominating para-
sympathetic activity during nighttime to increased 
sympathetic activity may lead to nocturnal hyperten-
sion and change in circadian blood pressure profile. 
Non-dipping hypertension was found in conditions 
associated with hypervolemia such as primary hyperal-
dosteronism or chronic kidney disease [46]. Both clin-
ical and experimental studies demonstrated that salt 
sensitivity is associated with hypervolemia and dimin-
ished natriuretic and diuretic responses to sodium load; 
therefore, it can be suspected that in sodium-sensitive 
patients, high sodium intake may deteriorate the blood 
pressure circadian rhythm. In salt-sensitive patients, the 
attenuated blood pressure nocturnal fall in response to 
high sodium diet may be explained, at least partially, by 
changes in the renin-angiotensin-aldosterone system. 
Brandenburger et al. [47] demonstrated that a decrease 
in renin release during the night was responsible for 
the magnitude of blood pressure nocturnal fall. They 
showed that inhibition of the renin-angiotensin-aldo-
sterone system in response to sodium load resulted in 
the significant reduction of circadian differences in the 
day-and nighttime blood pressure. Similarly, our study 
demonstrated lower plasma renin activity on a high 
sodium diet in comparison with low sodium diet sug-
gesting that ineffective inhibition of the renin-angio-
tensin-aldosterone system in salt-sensitive patients may 
contribute to the diminished nocturnal blood pressure 
fall. On each of the diet 24-h ABPM was performed.
Conclusions
1. Aside of significant blood pressure rise, in pa-
tients with hypertension a high sodium diet in-
duced the diminution of nocturnal fall.
2. Our results suggest that in salt-sensitive patients 
the reduction of salt intake may decrease blood 
pressure and restore its circadian profile and thus 
lead to the reduction in the rate of complications 
of hypertension.
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